Larvol Delta - Axsome-Therapeuticsannounced-that-the-rst-patient-has-been-dosed-in-the-FOCUS2-Phase-3-trial-evaluating-solriamfetol-as-a-treatment-for-children-with-attention-decit-hyperactivity-disorder-ADHD

Sunosi (solriamfetol) - Axsome Therap, Pharmanovia

https://www.globenewswire.com/news-release/2026/07/07/3323028/0/en/Axsome-Therapeutics-Initiates-FOCUS-2-Phase-3-Trial-of-Solriamfetol-in-Children-with-Attention-Deficit-Hyperactivity-Disorder-ADHD.html

Jul 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next